Telemedicine for the treatment of heart failure: new opportunities after COVID-19.
Journal
Journal of cardiovascular medicine (Hagerstown, Md.)
ISSN: 1558-2035
Titre abrégé: J Cardiovasc Med (Hagerstown)
Pays: United States
ID NLM: 101259752
Informations de publication
Date de publication:
01 10 2023
01 10 2023
Historique:
medline:
31
8
2023
pubmed:
6
7
2023
entrez:
6
7
2023
Statut:
ppublish
Résumé
During the Coronavirus Disease 2019 (COVID-19) pandemic, the epidemiology of heart failure significantly changed with reduced access to health system resources and a worsening of patients' outcome. Understanding the causes of these phenomena could be important to refine the management of heart failure during and after the pandemic. Telemedicine was associated with an improvement in heart failure outcomes in several studies; therefore, it may help in refining the out-of-hospital care of heart failure. In this review, the authors describe the changes in heart failure epidemiology during the COVID-19 pandemic; analyse available evidence on use and benefit of telemedicine during the pandemic and prepandemic periods; and discuss approaches to optimize the home-based or outpatient heart failure management in the future, beyond the pandemic.
Identifiants
pubmed: 37409660
doi: 10.2459/JCM.0000000000001514
pii: 01244665-202310000-00002
doi:
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
700-707Informations de copyright
Copyright © 2023 Italian Federation of Cardiology - I.F.C. All rights reserved.
Références
Keshvani N, Mehta A, Alger HM, et al. Heart failure quality of care and in-hospital outcomes during the COVID -19 pandemic: findings from the Get With The Guidelines-Heart Failure registry. Eur J Heart Fail 2022; 24:1117–1128.
Cannata A, Watson SA, Daniel A, et al. Impact of the COVID-19 pandemic on in-hospital mortality in cardiovascular disease: a meta-analysis. Eur J Prev Cardiol 2022; 29:1266–1274.
Bhatt AS, Moscone A, McElrath EE, et al. Fewer hospitalizations for acute cardiovascular conditions during the COVID-19 pandemic. J Am Coll Cardiol 2020; 76:280–288.
Cannatà A, Bromage DI, Rind IA, et al. Temporal trends in decompensated heart failure and outcomes during COVID-19: a multisite report from heart failure referral centres in London. Eur J Heart Fail 2020; 22:2219–2224.
Hall ME, Vaduganathan M, Khan MS, et al. Reductions in heart failure hospitalizations during the COVID-19 pandemic. J Cardiac Fail 2020; 26:462–463.
Cannatà A, Bromage DI, McDonagh TA. COVID-19 and heart failure: the dark side of the moon. Eur J Heart Fail 2022; 24:1129–1131.
Banerjee A, Chen S, Pasea L, et al. Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic. Eur J Prev Cardiol 2021; 28:1599–1609.
Butt JH, Fosbøl EL, Gerds TA, et al. All-cause mortality and location of death in patients with established cardiovascular disease before, during, and after the COVID-19 lockdown: a Danish Nationwide Cohort Study. Eur Heart J 2021; 42:1516–1523.
Bromage DI, Cannatà A, Rind IA, et al. The impact of COVID-19 on heart failure hospitalization and management: report from a Heart Failure Unit in London during the peak of the pandemic. Eur J Heart Fail 2020; 22:978–984.
Lin MH, Yuan WL, Huang TC, Zhang HF, Mai JT, Wang JF. Clinical effectiveness of telemedicine for chronic heart failure: a systematic review and meta-analysis. J Invest Med 2017; 65:899–911.
Koehler F, Winkler S, Schieber M, et al. Telemedical Interventional Monitoring in Heart Failure (TIM-HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design. Eur J Heart Fail 2010; 12:1354–1362.
Galinier M, Roubille F, Berdague P, et al. Telemonitoring versus standard care in heart failure: a randomised multicentre trial. Eur J Heart Fail 2020; 22:985–994.
Krzesiński P, Jankowska EA, Siebert J, et al. Effects of an outpatient intervention comprising nurse-led noninvasive assessments, telemedicine support and remote cardiologists’ decisions in patients with heart failure (AMULET study): a randomised controlled trial. Eur J Heart Fail 2022; 24:565–577.
Rosano GMC, Vitale C, Adamo M, Metra M. Roadmap for the management of heart failure patients during the vulnerable phase after heart failure hospitalizations: how to implement excellence in clinical practice. J Cardiovasc Med 2022; 23:149–156.
Zorzi A, Vio R, Rivezzi F, et al. Characteristics and hospital course of patients admitted for acute cardiovascular diseases during the coronavirus disease-19 outbreak. J Cardiovasc Med (Hagerstown) 2021; 22:29–35.
Crea F. European Society of Cardiology guidance for the management of cardiovascular disease during the pandemic and a focus on long COVID. Eur Heart J 2022; 43:1017–1021.
Fabris E, Bessi R, De Bellis A, et al. COVID-19 impact on ST-elevation myocardial infarction incidence rate in a Italian STEMI network: a U-shaped curve phenomenon. J Cardiovasc Med (Hagerstown) 2021; 22:344–349.
Cannatà A, Bromage DI. the collateral cardiovascular damage of COVID 19: only history will reveal the depth of the iceberg. MdDonagh Theresa A 2021; 42:1524–1527.
Rosano GMC, Celant S, Olimpieri PP, et al. Impact of the COVID-19 pandemic on prescription of sacubitril/valsartan in Italy. Eur J Heart Fail 2022; 24:855–860.
Faragli A, La Porta E, Campana C, et al. Out-of-hospital care of heart failure patients during and after COVID-19 pandemic: time for telemedicine? Front Digit Health 2020; 2:593885.
Salzano A, D’Assante R, Stagnaro FM, et al. Heart failure management during the COVID-19 outbreak in Italy: a telemedicine experience from a heart failure university tertiary referral centre. Eur J Heart Fail 2020; 22:1048–1050.
Grandinetti M, Di Molfetta A, Graziani F, et al. Telemedicine for adult congenital heart disease patients during the first wave of COVID-19 era: a single center experience. J Cardiovasc Med (Hagerstown) 2021; 22:706–710.
Krzesiński P, Siebert J, Jankowska EA, et al. Rationale and design of the AMULET study: a new model of telemedical care in patients with heart failure. ESC Heart Fail 2021; 8:2569–2579.
Dierckx R, Inglis SC, Clark RA, Prieto-Merino D, Cleland JGF. Telemedicine in heart failure: new insights from the Cochrane meta-analyses. Eur J Heart Fail 2017; 19:304–306.
Inglis SC, Clark RA, McAlister FA, et al. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database Syst Rev 2010; CD007228.
Inglis SC, Clark RA, Dierckx R, Prieto-Merino D, Cleland JGF. Structured telephone support or noninvasive telemonitoring for patients with heart failure. Cochrane Database Syst Rev 2015; 2015:CD007228.
Zhu Y, Gu X, Xu C. Effectiveness of telemedicine systems for adults with heart failure: a meta-analysis of randomized controlled trials. Heart Fail Rev 2020; 25:231–243.
Soran OZ, Piña IL, Lamas GA, et al. A randomized clinical trial of the clinical effects of enhanced heart failure monitoring using a computer-based telephonic monitoring system in older minorities and women. J Card Fail 2008; 14:711–717.
Kulshreshtha A, Kvedar JC, Goyal A, Halpern EF, Watson AJ. Use of remote monitoring to improve outcomes in patients with heart failure: a pilot trial. Int J Telemed Appl 2010; 870959.
Chaudhry SI, Mattera JA, Curtis JP, et al. Telemonitoring in patients with heart failure. N Engl J Med 2010; 363:2301–2309.
Lyngå P, Persson H, Hägg-Martinell A, et al. Weight monitoring in patients with severe heart failure (WISH): a randomized controlled trial. Eur J Heart Fail 2012; 14:438–444.
Ong MK, Romano PS, Edgington S, et al. Effectiveness of remote patient monitoring after discharge of hospitalized patients with heart failure the better effectiveness after transition-heart failure (BEAT-HF) randomized clinical trial. JAMA Intern Med 2016; 176:310–318.
Krzesiński P. Digital health technologies for post-discharge care after heart failure hospitalisation to relieve symptoms and improve clinical outcomes. J Clin Med 2023; 12:2373.
Giordano A, Scalvini S, Zanelli E, et al. Multicenter randomised trial on home-based telemanagement to prevent hospital readmission of patients with chronic heart failure. Int J Cardiol 2009; 131:192–199.
Ferrante D, Varini S, Macchia A, et al. Long-term results after a telephone intervention in chronic heart failure: DIAL (randomized trial of phone intervention in chronic heart failure) follow-up. J Am Coll Cardiol 2010; 56:372–378.
Blum K, Gottlieb SS. The effect of a randomized trial of home telemonitoring on medical costs, 30-day readmissions, mortality, and health-related quality of life in a cohort of community-dwelling heart failure patients. J Card Fail 2014; 20:513–521.
Boyne JJJ, Vrijhoef HJM, Crijns HJGM, De Weerd G, Kragten J, Gorgels APM. Tailored telemonitoring in patients with heart failure: results of a multicentre randomized controlled trial. Eur J Heart Fail 2012; 14:791–801.
Angermann CE, Sehner S, Faller H, et al. Longer-term effects of remote patient management following hospital discharge after acute systolic heart failure: the randomized E-INH trial. JACC Heart Fail 2023; 11:191–206.
Krum H, Forbes A, Yallop J, et al. Telephone support to rural and remote patients with heart failure: the chronic heart failure assessment by telephone (CHAT) study. Cardiovasc Ther 2013; 31:230–237.
Whellan DJ, Ousdigian KT, Al-Khatib SM, et al. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations. Results from PARTNERS HF (Program to Access and Review Trending Information and Evaluate Correlation to Symptoms in Patients With Heart Failure) Study. J Am Coll Cardiol 2010; 55:1803–1810.
Boehmer JP, Hariharan R, Devecchi FG, et al. A multisensor algorithm predicts heart failure events in patients with implanted devices results from the MultiSENSE Study. JACC Heart Fail 2017; 5:216–225.
D’onofrio A, Solimene F, Calò L, et al. Combining home monitoring temporal trends from implanted defibrillators and baseline patient risk profile to predict heart failure hospitalizations: results from the SELENE HF study. Europace 2022; 24:234–244.
Calò L, Bianchi V, Ferraioli D, et al. Multiparametric implantable cardioverter-defibrillator algorithm for heart failure risk stratification and management: an analysis in clinical practice. Circ Heart Fail 2021; 14:E008134.
Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2016; 37:2129–2200.
Koehler F, Koehler K, Deckwart O, et al. Telemedical Interventional Management in Heart Failure II (TIM-HF2), a randomised, controlled trial investigating the impact of telemedicine on unplanned cardiovascular hospitalisations and mortality in heart failure patients: study design and description of the intervention. Eur J Heart Fail 2018; 20:1485–1493.
Seferovic PM, Ponikowski P, Anker SD, et al. Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2019: 1169--1186.
Cleland JGF, Clark RA, Pellicori P, Inglis SC. Caring for people with heart failure and many other medical problems through and beyond the COVID-19 pandemic: the advantages of universal access to home telemonitoring. Eur J Heart Fail 2020; 22:995–998.
Galinier M. STUDY PROTOCOL Optimization of the Ambulatory Monitoring for Patients With Heart Failure by Tele-cardiology (OSICAT). 27 Jun 2018.
Gori M, Bonmassari R, Correale M, et al. LEAP Virtual Visit Assessment (VIVA): a structured protocol for virtual visits for patients with heart failure. J Cardiovasc Med 2022; 23:685–690.
Koehler J, Stengel A, Hofmann T, et al. Telemonitoring in patients with chronic heart failure and moderate depressed symptoms: results of the Telemedical Interventional Monitoring in Heart Failure (TIM-HF) study. Eur J Heart Fail 2021; 23:186–194.
Greene SJ, Mentz RJ, Felker GM. Outpatient worsening heart failure as a target for therapy a review. JAMA Cardiol 2018; 3:252–259.
Girerd N, Mewton N, Tartière JM, et al. Practical outpatient management of worsening chronic heart failure. Eur J Heart Fail 2022; 24:750–761.
Greene SJ, Bauersachs J, Brugts JJ, et al. Worsening heart failure: nomenclature, epidemiology, and future directions: JACC review topic of the week. J Am Coll Cardiol 2023; 81:413–424.
Davison BA, Senger S, Sama IE, et al. Is acute heart failure a distinctive disorder? An analysis from BIOSTAT-CHF. Eur J Heart Fail 2021; 23:43–57.
Böhm M, Drexler H, Oswald H, et al. Fluid status telemedicine alerts for heart failure: a randomized controlled trial. Eur Heart J 2016; 37:3154–3163.
Assmus B, Angermann CE, Alkhlout B, et al. Effects of remote haemodynamic-guided heart failure management in patients with different subtypes of pulmonary hypertension: insights from the MEMS-HF study. Eur J Heart Fail 2022; 24:2320–2330.
Aviv T. EUR/RC72/5: Regional digital health action plan for the WHO European Region 2023–2030. 2022 [Online]. https://apps.who.int/iris/handle/10665/343164 . [Accessed 12 May 2023]
EUROPEAN COMMISSION. Proposal for a REGULATION OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the European Health Data Space. Belgium: European Commission; 2022.
GAZZETTA UFFICIALE DELLA REPUBBLICA ITALIANA - DECRETO 21 settembre 2022 Approvazione delle linee guida per i servizi di telemedicina - Requisiti funzionali e livelli di servizio (22A06184) (GU Serie Generale n.256 del 02-11-2022).